The clinical significance of endotoxin released by antibiotics

What is the evidence?

C. N. Mock, Gregory Jurkovich, D. Dries, R. V. Maier

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Basic investigations indicate variation among antibiotics in their propensity to release endotoxin from bacterial cells. Evidence for the clinical significance of this phenomenon includes: anecdotal reports; studies evaluating changes in endotoxin levels in response to antibiotics in a variety of infectious diseases; two studies which have prospectively evaluated changes in endotoxin levels in response to different antibiotics and correlated the changes with the patients' clinical course; and one study which evaluated differences in mortality in injured patients based on the endotoxin-releasing potential of antibiotics they received. These studies suggest: (i) different types of antibiotics do induce differing levels of endotoxin release during treatment of bacterial infections in humans; (ii) such antibiotic-associated endotoxin release probably does have a biologic consequence; and (iii) this biologic consequence is possibly of clinical relevance. However, the data are not sufficient to advocate changes in current antibiotic prescribing or dosing decisions. Rather, a variety of in vitro and in vivo experiments as well as clinical studies are advocated.

Original languageEnglish (US)
Pages (from-to)253-259
Number of pages7
JournalInnate Immunity
Volume3
Issue number3
DOIs
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Endotoxins
Anti-Bacterial Agents
Bacterial Infections
Communicable Diseases
Mortality

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Immunology
  • Microbiology
  • Infectious Diseases

Cite this

The clinical significance of endotoxin released by antibiotics : What is the evidence? / Mock, C. N.; Jurkovich, Gregory; Dries, D.; Maier, R. V.

In: Innate Immunity, Vol. 3, No. 3, 01.12.1996, p. 253-259.

Research output: Contribution to journalArticle

Mock, C. N. ; Jurkovich, Gregory ; Dries, D. ; Maier, R. V. / The clinical significance of endotoxin released by antibiotics : What is the evidence?. In: Innate Immunity. 1996 ; Vol. 3, No. 3. pp. 253-259.
@article{3581b32198a54ef29ad2505e8cc4b008,
title = "The clinical significance of endotoxin released by antibiotics: What is the evidence?",
abstract = "Basic investigations indicate variation among antibiotics in their propensity to release endotoxin from bacterial cells. Evidence for the clinical significance of this phenomenon includes: anecdotal reports; studies evaluating changes in endotoxin levels in response to antibiotics in a variety of infectious diseases; two studies which have prospectively evaluated changes in endotoxin levels in response to different antibiotics and correlated the changes with the patients' clinical course; and one study which evaluated differences in mortality in injured patients based on the endotoxin-releasing potential of antibiotics they received. These studies suggest: (i) different types of antibiotics do induce differing levels of endotoxin release during treatment of bacterial infections in humans; (ii) such antibiotic-associated endotoxin release probably does have a biologic consequence; and (iii) this biologic consequence is possibly of clinical relevance. However, the data are not sufficient to advocate changes in current antibiotic prescribing or dosing decisions. Rather, a variety of in vitro and in vivo experiments as well as clinical studies are advocated.",
author = "Mock, {C. N.} and Gregory Jurkovich and D. Dries and Maier, {R. V.}",
year = "1996",
month = "12",
day = "1",
doi = "10.1177/096805199600300311",
language = "English (US)",
volume = "3",
pages = "253--259",
journal = "Innate Immunity",
issn = "1753-4259",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - The clinical significance of endotoxin released by antibiotics

T2 - What is the evidence?

AU - Mock, C. N.

AU - Jurkovich, Gregory

AU - Dries, D.

AU - Maier, R. V.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Basic investigations indicate variation among antibiotics in their propensity to release endotoxin from bacterial cells. Evidence for the clinical significance of this phenomenon includes: anecdotal reports; studies evaluating changes in endotoxin levels in response to antibiotics in a variety of infectious diseases; two studies which have prospectively evaluated changes in endotoxin levels in response to different antibiotics and correlated the changes with the patients' clinical course; and one study which evaluated differences in mortality in injured patients based on the endotoxin-releasing potential of antibiotics they received. These studies suggest: (i) different types of antibiotics do induce differing levels of endotoxin release during treatment of bacterial infections in humans; (ii) such antibiotic-associated endotoxin release probably does have a biologic consequence; and (iii) this biologic consequence is possibly of clinical relevance. However, the data are not sufficient to advocate changes in current antibiotic prescribing or dosing decisions. Rather, a variety of in vitro and in vivo experiments as well as clinical studies are advocated.

AB - Basic investigations indicate variation among antibiotics in their propensity to release endotoxin from bacterial cells. Evidence for the clinical significance of this phenomenon includes: anecdotal reports; studies evaluating changes in endotoxin levels in response to antibiotics in a variety of infectious diseases; two studies which have prospectively evaluated changes in endotoxin levels in response to different antibiotics and correlated the changes with the patients' clinical course; and one study which evaluated differences in mortality in injured patients based on the endotoxin-releasing potential of antibiotics they received. These studies suggest: (i) different types of antibiotics do induce differing levels of endotoxin release during treatment of bacterial infections in humans; (ii) such antibiotic-associated endotoxin release probably does have a biologic consequence; and (iii) this biologic consequence is possibly of clinical relevance. However, the data are not sufficient to advocate changes in current antibiotic prescribing or dosing decisions. Rather, a variety of in vitro and in vivo experiments as well as clinical studies are advocated.

UR - http://www.scopus.com/inward/record.url?scp=79957698659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957698659&partnerID=8YFLogxK

U2 - 10.1177/096805199600300311

DO - 10.1177/096805199600300311

M3 - Article

VL - 3

SP - 253

EP - 259

JO - Innate Immunity

JF - Innate Immunity

SN - 1753-4259

IS - 3

ER -